Benefit-Risk Assessment of Transdermal Fentanyl for the Treatment of Chronic Pain (Q35570047)

8 August 2017

1 reference

title

Benefit-risk assessment of transdermal fentanyl for the treatment of chronic pain (English)

1 reference

8 August 2017

Benefit-Risk Assessment of Transdermal Fentanyl for the Treatment of Chronic Pain (English)

1 reference

https://api.crossref.org/works/10.2165/00002018-200326130-00004

26 March 2024

0 references

0 references

1 reference

https://api.crossref.org/works/10.2165/00002018-200326130-00004

26 March 2024

author name string

Juan Santiago-Palma

2

1 reference

8 August 2017

Natalia Moryl

3

1 reference

8 August 2017

Richard Payne

4

1 reference

8 August 2017

Craig A. Kornick

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14583070

26 March 2024

Eugenie A. M T. Obbens

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14583070

26 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14583070

26 March 2024

publication date

1 January 2003

1 reference

8 August 2017

1 reference

8 August 2017

volume

26

1 reference

8 August 2017

issue

13

1 reference

8 August 2017

page(s)

951-973

1 reference

Transdermal fentanyl versus sustained-release oral morphine in cancer pain: preference, efficacy, and quality of life. The TTS-Fentanyl Comparative Trial Group

8 August 2017

cites work

1 reference

12 December 2020

Guidelines for the clinical use of transdermal fentanyl

1 reference

12 December 2020

Direct conversion from oral morphine to transdermal fentanyl: a multicenter study in patients with cancer pain

1 reference

12 December 2020

Pharmacologic management of acute and chronic pain: focus on drug interactions and patient-specific pharmacotherapeutic selection

1 reference

12 December 2020

A double-blind, placebo-controlled trial of transdermal fentanyl after abdominal hysterectomy. Analgesic, respiratory, and pharmacokinetic effects.

1 reference

12 December 2020

Day-to-day titration to initiate transdermal fentanyl in patients with cancer pain: short- and long-term experiences in a prospective study of 39 patients.

1 reference

12 December 2020

Fatal fentanyl intoxication following excessive transdermal application.

1 reference

12 December 2020

Opioid rotation in patients with cancer pain. A retrospective comparison of dose ratios between methadone, hydromorphone, and morphine

1 reference

12 December 2020

Opioid overdose in a patient using a fentanyl patch during treatment with a warming blanket

1 reference

12 December 2020

Transdermal fentanyl in opioid-naive cancer pain patients: an open trial using transdermal fentanyl for the treatment of chronic cancer pain in opioid-naive patients and a group using codeine

1 reference

12 December 2020

Day-to-day titration of transdermal fentanyl is unwise.

1 reference

12 December 2020

Withdrawal with transdermal fentanyl.

1 reference

12 December 2020

Transdermal fentanyl for pain control in patients with cancer

1 reference

12 December 2020

Comparison of oral controlled-release morphine with transdermal fentanyl in terminal cancer pain.

1 reference

12 December 2020

Randomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain

1 reference

12 December 2020

Transdermal fentanyl: clinical trial at the University of Colorado Health Sciences Center

1 reference

12 December 2020

Chronic use of opioid analgesics in non-malignant pain: report of 38 cases

1 reference

12 December 2020

Evaluation of long-term efficacy and safety of transdermal fentanyl in the treatment of chronic noncancer pain.

1 reference

12 December 2020

Absorption characteristics of transdermally administered fentanyl

1 reference

12 December 2020

1 reference

12 December 2020

Transdermal fentanyl: long-term analgesic studies

1 reference

12 December 2020

Transdermal fentanyl in children with cancer pain: feasibility, tolerability, and pharmacokinetic correlates

1 reference

12 December 2020

Transdermal fentanyl during high-dose chemotherapy and autologous stem cell support.

1 reference

12 December 2020

The treatment of cancer pain

1 reference

12 December 2020

Dose ratio between morphine and methadone in patients with cancer pain: a retrospective study

1 reference

12 December 2020

Long-term treatment of cancer pain with transdermal fentanyl

1 reference

12 December 2020

Opioids in nonmalignant pain: questions in search of answers

1 reference

12 December 2020

Transdermal fentanyl as treatment for chronic low back pain

1 reference

12 December 2020

Transdermal fentanyl for cancer pain. Repeated dose pharmacokinetics.

1 reference

12 December 2020

Long-term use of opioid analgesics for the treatment of chronic pain of nonmalignant origin

1 reference

12 December 2020

Transdermal fentanyl therapy: system design, pharmacokinetics and efficacy

1 reference

12 December 2020

Withdrawal symptoms during therapy with transdermal fentanyl (fentanyl TTS)?

1 reference

12 December 2020

Chronic opioid therapy in nonmalignant pain

1 reference

12 December 2020

Long-acting opioids for chronic pain: pharmacotherapeutic opportunities to enhance compliance, quality of life, and analgesia

1 reference

12 December 2020

A clinical evaluation of transdermal therapeutic system fentanyl for the treatment of cancer pain

1 reference

12 December 2020

Fentanyl remaining in a transdermal system following three days of continuous use.

1 reference

12 December 2020

Management of cancer pain with transdermal fentanyl: phase IV trial, University of Iowa

1 reference

12 December 2020

Fentanyl patches left on dead bodies -- potential source of drug for abusers.

1 reference

12 December 2020

Quicker dosage adjustment for transdermal fentanyl.

1 reference

12 December 2020

Myoclonus secondary to withdrawal from transdermal fentanyl: case report and literature review.

1 reference

12 December 2020

Transdermal fentanyl and initial dose-finding with patient-controlled analgesia in cancer pain. A pilot study with 20 terminally ill cancer patients

1 reference

12 December 2020

Randomised trial of oral morphine for chronic non-cancer pain

1 reference

12 December 2020

Implementation of a formal treatment agreement for outpatient management of chronic nonmalignant pain with opioid analgesics

1 reference

12 December 2020

Inhalation abuse of fentanyl patch

1 reference

12 December 2020

Inappropriate use of transdermal fentanyl for acute postoperative pain.

1 reference

12 December 2020

Prevention of nausea and vomiting (N&V) in cancer patients receiving high-dose cisplatin. Assessment of the potential antiemetic activity of transdermal fentanyl (TTS-F) compared to standard antiemetic treatment in acute and delayed N&V: first clini

1 reference

12 December 2020

Transdermal fentanyl: pharmacokinetics and preliminary clinical evaluation.

1 reference

12 December 2020

Perioperative pharmacokinetics of transdermal fentanyl in elderly and young adult patients.

1 reference

12 December 2020

Respiratory failure due to the combined effects of transdermal fentanyl and epidural bupivacaine/diamorphine following radical nephrectomy

1 reference

12 December 2020

Transdermal fentanyl: suggested recommendations for clinical use

1 reference

12 December 2020

Decreased fentanyl and alfentanil dose requirements with age. A simultaneous pharmacokinetic and pharmacodynamic evaluation

1 reference

12 December 2020

[Opioid intoxication. Inappropriate administration of transdermal fentanyl]

1 reference

12 December 2020

System functionality and physicochemical model of fentanyl transdermal system.

1 reference

12 December 2020

Morphine and alternative opioids in cancer pain: the EAPC recommendations

1 reference

12 December 2020

Clinicians' attitudes about prolonged use of opioids and the issue of patient heterogeneity

1 reference

12 December 2020

Postoperative analgesia with fentanyl: pharmacokinetics and pharmacodynamics of constant-rate i.v. and transdermal delivery

1 reference

12 December 2020

Quality of life and cancer pain: satisfaction and side effects with transdermal fentanyl versus oral morphine

1 reference

12 December 2020

The efficacy of transdermal fentanyl in the treatment of postoperative pain: a double-blind comparison of fentanyl and placebo systems

1 reference

12 December 2020

Transdermal drug delivery system exposure outcomes

1 reference

12 December 2020

Respiratory changes during treatment of postoperative pain with high dose transdermal fentanyl

1 reference

12 December 2020

Constipation and the use of laxatives: a comparison between transdermal fentanyl and oral morphine.

1 reference

12 December 2020

A fatal overdose of transdermally administered fentanyl.

1 reference

12 December 2020

Risk-benefit assessment of opioids in chronic noncancer pain

1 reference

12 December 2020

Acute toxic delirium: an uncommon reaction to transdermal fentanyl

1 reference

12 December 2020

Opioid rotation for toxicity reduction in terminal cancer patients

1 reference

12 December 2020

An alternative algorithm for dosing transdermal fentanyl for cancer-related pain

1 reference

12 December 2020

Individual variability in the response to different opioids: report of five cases

1 reference

12 December 2020

Clinical pharmacokinetics of alfentanil, fentanyl and sufentanil. An update

1 reference

12 December 2020

Factors influencing quality of life in cancer patients: the role of transdermal fentanyl in the management of pain.

1 reference

12 December 2020

Transdermally administered fentanyl for pain management

1 reference

12 December 2020

Opioid therapy for chronic nonmalignant pain: a review of the critical issues

1 reference

12 December 2020

The transdermal administration of fentanyl in the treatment of postoperative pain: pharmacokinetics and pharmacodynamic effects

1 reference

12 December 2020

Transdermal fentanyl and the opioid withdrawal syndrome

1 reference

12 December 2020

Transdermal fentanyl in the long-term treatment of cancer pain: a prospective study of 50 patients with advanced cancer of the gastrointestinal tract or the head and neck region.

1 reference

12 December 2020

Transdermal fentanyl use in hospice home-care patients with chronic cancer pain

1 reference

12 December 2020

Opioid rotation for cancer pain: rationale and clinical aspects

1 reference

12 December 2020

1 reference

12 December 2020

Transdermal fentanyl. A review of its pharmacological properties and therapeutic efficacy in pain control

1 reference

12 December 2020

Respiratory depression in a child unintentionally exposed to transdermal fentanyl patch.

1 reference

12 December 2020

Character of terminal illness in the advanced cancer patient: pain and other symptoms during the last four weeks of life

1 reference

12 December 2020

Clinical pharmacokinetics of fentanyl and its newer derivatives.

1 reference

12 December 2020

Transdermal fentanyl in the management of cancer pain in ambulatory patients: an open-label pilot study

1 reference

12 December 2020

Transdermal fentanyl: clinical pharmacology.

1 reference

12 December 2020

A safe and effective method for converting patients from transdermal to intravenous fentanyl for the treatment of acute cancer-related pain

1 reference

12 December 2020

Which potent opioid? Important criteria for selection

1 reference

12 December 2020

Switching opioids to transdermal fentanyl in a clinical setting

1 reference

12 December 2020

Economic evaluation of the fentanyl transdermal system for the treatment of chronic moderate to severe pain

1 reference

12 December 2020

Potential dangers related to transdermal fentanyl (Duragesic) when used for postoperative pain.

1 reference

12 December 2020

Transdermal fentanyl for the management of cancer pain: a survey of 1005 patients

1 reference

12 December 2020

Acute toxic delirium in a patient using transdermal fentanyl

1 reference

12 December 2020

Fentanyl transdermal system overdose secondary to cutaneous hyperthermia.

1 reference

12 December 2020

Management of pain in the cancer patient

1 reference

12 December 2020

Effects of temperature on blood circulation measured with the laser Doppler method

1 reference

12 December 2020

Prolonged treatment with transdermal fentanyl in neuropathic pain

1 reference

12 December 2020

Fentanyl transdermal system. Pain management at home

1 reference

12 December 2020

Plasma fentanyl concentrations during transdermal delivery of fentanyl to surgical patients.

1 reference

12 December 2020

Intravenous abuse of transdermal fentanyl therapy in a chronic pain patient.

1 reference

12 December 2020

Dose ratio between morphine and hydromorphone in patients with cancer pain: a retrospective study

1 reference

12 December 2020

Postoperative analgesia with transdermal fentanyl following lower abdominal surgery.

1 reference

12 December 2020

Clinical pharmacokinetics of transdermal opioids: focus on transdermal fentanyl

1 reference

12 December 2020

Transdermal delivery of narcotic analgesics: pH, anatomical, and subject influences on cutaneous permeability of fentanyl and sufentanil

1 reference

12 December 2020

From the Food and Drug Administration

1 reference

12 December 2020

Controversies in the long-term management of analgesic therapy in patients with advanced cancer

49

1 reference

https://api.crossref.org/works/10.2165/00002018-200326130-00004

Management of chronic pain. Part I.

26 March 2024

58

1 reference

https://api.crossref.org/works/10.2165/00002018-200326130-00004

Hospital pharmacist report

26 March 2024

62

12

11

Vecchione

1995

1 reference

https://api.crossref.org/works/10.2165/00002018-200326130-00004

26 March 2024

87

32

75

Marquardt

1994

1 reference

https://api.crossref.org/works/10.2165/00002018-200326130-00004

26 March 2024

98

11

22

Calis

1992

1 reference

https://api.crossref.org/works/10.2165/00002018-200326130-00004

26 March 2024

Identifiers

1 reference

Dimensions Publication ID

8 August 2017

1010400283

0 references

1 reference